Literature DB >> 23263895

Characteristics, treatment, and outcomes of periprocedural cerebrovascular accidents during electrophysiologic procedures.

Serge C Harb1, George Thomas, Walid I Saliba, Georges N Nakhoul, Ayman A Hussein, Valeria E Duarte, Mandeep Bhargava, Bryan Baranowski, Patrick Tchou, Thomas Dresing, Thomas Callahan, Mohamed Kanj, Andrea Natale, Bruce D Lindsay, Oussama M Wazni.   

Abstract

OBJECTIVES: We sought to identify the characteristics, treatment, and outcomes of periprocedural cerebrovascular accident (PCVA) during electrophysiologic (EP) procedures.
BACKGROUND: Periprocedural cerebrovascular accident is one of the most feared complications during EP procedures with very few data regarding its characteristics, management, and outcomes.
METHODS: Between January 1998 and December 2008, we reviewed 30,032 invasive EP procedures for PCVA occurrence and characteristics. Management and outcomes were also determined.
RESULTS: Thirty-eight CVAs were identified. Twenty (53 %) were intraprocedural and 18 (47 %) postprocedural. Thirty-two (84 %) were classified as strokes and six (16 %) as transient ischemic attacks. All CVAs except one (37, 97 %) were ischemic and the vast majority occurred during ablation procedures (36, 95 %). Among the 31 patients with ischemic stroke, 11 (35 %) were treated with reperfusion (eight catheter-based therapy and three intravenous t-PA) of whom five (46 %) had complete recovery, three (27 %) had partial recovery, and three (27 %) had no recovery. No hemorrhagic transformations occurred.
CONCLUSION: Periprocedural cerebrovascular accident during EP procedures is rare and is almost always ischemic. It occurs more frequently during ablation procedures. Reperfusion therapy is feasible and safe.

Entities:  

Mesh:

Year:  2012        PMID: 23263895     DOI: 10.1007/s10840-012-9766-2

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  24 in total

1.  Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention.

Authors:  K M Akkerhuis; J W Deckers; A M Lincoff; J E Tcheng; E Boersma; K Anderson; C Balog; R M Califf; E J Topol; M L Simoons
Journal:  JAMA       Date:  2001-07-04       Impact factor: 56.272

Review 2.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

3.  Management of cerebrovascular accidents during cardiac catheterization: immediate cerebral angiography versus early neuroimaging strategy.

Authors:  Federico De Marco; José Antonio Fernandez-Diaz; Thierry Lefèvre; Jordi Balcells; Mario Araya; Helen Routledge; Andrés Rosas; Yves Louvard; Pierre Dumas; Marie-Claude Morice
Journal:  Catheter Cardiovasc Interv       Date:  2007-10-01       Impact factor: 2.692

4.  Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications.

Authors:  L W Johnson; E C Lozner; S Johnson; R Krone; A D Pichard; G W Vetrovec; T J Noto
Journal:  Cathet Cardiovasc Diagn       Date:  1989-05

5.  Complications of diagnostic electrophysiologic studies and radiofrequency catheter ablation in patients with tachyarrhythmias: an eight-year survey of 3,966 consecutive procedures in a tertiary referral center.

Authors:  S A Chen; C E Chiang; C T Tai; C C Cheng; C W Chiou; S H Lee; K C Ueng; Z C Wen; M S Chang
Journal:  Am J Cardiol       Date:  1996-01-01       Impact factor: 2.778

6.  Stroke as a complication of cardiac catheterization: risk factors and clinical features.

Authors:  A Z Segal; W B Abernethy; I F Palacios; R BeLue; G Rordorf
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

7.  Intra-arterial thrombolytic therapy in peri-coronary angiography ischemic stroke.

Authors:  Osama O Zaidat; Andy P Slivka; Yousef Mohammad; Carmelo Graffagnino; Tony P Smith; David S Enterline; Greg A Christoforidis; Michael J Alexander; Dennis M D Landis; Jose I Suarez
Journal:  Stroke       Date:  2005-03-31       Impact factor: 7.914

8.  Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.

Authors:  Oussama M Wazni; Salwa Beheiry; Tamer Fahmy; Conor Barrett; Steven Hao; Dimpi Patel; Luigi Di Biase; David O Martin; Mohamed Kanj; Mauricio Arruda; Jennifer Cummings; Robert Schweikert; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2007-11-12       Impact factor: 29.690

9.  Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy.

Authors:  Ayman A Hussein; David O Martin; Walid Saliba; Deven Patel; Saima Karim; Omar Batal; Mustafa Banna; Michelle Williams-Andrews; Minerva Sherman; Mohamed Kanj; Mandeep Bhargava; Thomas Dresing; Thomas Callahan; Patrick Tchou; Luigi Di Biase; Salwa Beheiry; Bruce Lindsay; Andrea Natale; Oussama Wazni
Journal:  Heart Rhythm       Date:  2009-07-10       Impact factor: 6.343

10.  Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications.

Authors:  Shmuel Fuchs; Eugenio Stabile; Timothy D Kinnaird; Gary S Mintz; Luis Gruberg; Daniel A Canos; Ellen E Pinnow; Ran Kornowski; William O Suddath; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; Neil J Weissman
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.